George Bartzokis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
George Bartzokis has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Jim Mintz
23 shared publicationsPo H. Lu
The David Geffen School of Medicine at UCLA
21 shared publicationsLori L. Altshuler
8 shared publicationsKeith H. Nuechterlein
Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, The David Geffen School of Medicine at UCLA, Los Angeles, California
7 shared publicationsNancy Edwards
Department of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
7 shared publicationsTodd A. Tishler
Department of Psychiatry and Biobehavioral Sciences, The David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
6 shared publications
Latest Publications
- 12 December 2014
- Published by Springer Nature
- Vol. 2014, 13-22
Rich Club Network Analysis Shows Distinct Patterns of Disruption in Frontotemporal Dementia and Alzheimer’s Disease
Diffusion imaging and brain connectivity analyses can reveal the underlying organizational patterns of the human brain, described as complex networks of densely interlinked regions. Here, we analyzed 1.5-Tesla whole-brain diffusion-weighted images from 64 participants—15 patients with behavioral variant frontotemporal (bvFTD) dementia, 19 with early-onset Alzheimer’s disease (EOAD), and 30 healthy elderly controls. Based on whole-brain tractography, we reconstructed structural brain connectivity networks to map connections between cortical regions. We examined how bvFTD and EOAD disrupt the weighted ‘rich club’—a network property where high-degree network nodes are more interconnected than expected by chance. bvFTD disrupts both the nodal and global organization of the network in both low- and high-degree regions of the brain. EOAD targets the global connectivity of the brain, mainly affecting the fiber density of high-degree (highly connected) regions that form the rich club network. These rich club analyses suggest distinct patterns of disruptions among different forms of dementia.
- 12 December 2014
- Published by Springer Nature
- Vol. 2014, 13-22
Rich Club Network Analysis Shows Distinct Patterns of Disruption in Frontotemporal Dementia and Alzheimer’s Disease
Diffusion imaging and brain connectivity analyses can reveal the underlying organizational patterns of the human brain, described as complex networks of densely interlinked regions. Here, we analyzed 1.5-Tesla whole-brain diffusion-weighted images from 64 participants—15 patients with behavioral variant frontotemporal (bvFTD) dementia, 19 with early-onset Alzheimer’s disease (EOAD), and 30 healthy elderly controls. Based on whole-brain tractography, we reconstructed structural brain connectivity networks to map connections between cortical regions. We examined how bvFTD and EOAD disrupt the weighted ‘rich club’—a network property where high-degree network nodes are more interconnected than expected by chance. bvFTD disrupts both the nodal and global organization of the network in both low- and high-degree regions of the brain. EOAD targets the global connectivity of the brain, mainly affecting the fiber density of high-degree (highly connected) regions that form the rich club network. These rich club analyses suggest distinct patterns of disruptions among different forms of dementia.
Myelination, oligodendrocytes, and serious mental illness
Historically, the human brain has been conceptually segregated from the periphery and further dichotomized into gray matter (GM) and white matter (WM) based on the whitish appearance of the exceptionally high lipid content of the myelin sheaths encasing neuronal axons. These simplistic dichotomies were unfortunately extended to conceptually segregate neurons from glia, cognition from behavior, and have been codified in the separation of clinical and scientific fields into medicine, psychiatry, neurology, pathology, etc. The discrete classifications have helped obscure the importance of continual dynamic communication between all brain cell types (neurons, astrocytes, microglia, oligodendrocytes, and precursor (NG2) cells) as well as between brain and periphery through multiple signaling systems. The signaling systems range from neurotransmitters to insulin, angiotensin, and multiple kinases such a glycogen synthase kinase 3 (GSK‐3) that together help integrate metabolism, inflammation, and myelination processes and orchestrate the development, plasticity, maintenance, and repair that continually optimize function of neural networks. A more comprehensive, evolution‐based, systems biology approach that integrates brain, body, and environmental interactions may ultimately prove more fruitful in elucidating the complexities of human brain function. The historic focus on neurons/GM is rebalanced herein by highlighting the importance of a systems‐level understanding of the interdependent age‐related shifts in both central and peripheral homeostatic mechanisms that can lead to remarkably prevalent and devastating neuropsychiatric diseases. Herein we highlight the role of glia, especially the most recently evolved oligodendrocytes and the myelin they produce, in achieving and maintaining optimal brain function. The human brain undergoes exceptionally protracted and pervasive myelination (even throughout its GM) and can thus achieve and maintain the rapid conduction and synchronous timing of neural networks on which optimal function depends. The continuum of increasing myelin vulnerability resulting from the human brain's protracted myelination underlies underappreciated communalities between different disease phenotypes ranging from developmental ones such as schizophrenia (SZ) and bipolar disorder (BD) to degenerative ones such as Alzheimer's disease (AD). These shared vulnerabilities also expose significant yet underexplored opportunities for novel treatment and prevention approaches that have the potential to considerably reduce the tremendous burden of neuropsychiatric disease. GLIA 2014;62:1856–1877
Myelination, oligodendrocytes, and serious mental illness
Historically, the human brain has been conceptually segregated from the periphery and further dichotomized into gray matter (GM) and white matter (WM) based on the whitish appearance of the exceptionally high lipid content of the myelin sheaths encasing neuronal axons. These simplistic dichotomies were unfortunately extended to conceptually segregate neurons from glia, cognition from behavior, and have been codified in the separation of clinical and scientific fields into medicine, psychiatry, neurology, pathology, etc. The discrete classifications have helped obscure the importance of continual dynamic communication between all brain cell types (neurons, astrocytes, microglia, oligodendrocytes, and precursor (NG2) cells) as well as between brain and periphery through multiple signaling systems. The signaling systems range from neurotransmitters to insulin, angiotensin, and multiple kinases such a glycogen synthase kinase 3 (GSK‐3) that together help integrate metabolism, inflammation, and myelination processes and orchestrate the development, plasticity, maintenance, and repair that continually optimize function of neural networks. A more comprehensive, evolution‐based, systems biology approach that integrates brain, body, and environmental interactions may ultimately prove more fruitful in elucidating the complexities of human brain function. The historic focus on neurons/GM is rebalanced herein by highlighting the importance of a systems‐level understanding of the interdependent age‐related shifts in both central and peripheral homeostatic mechanisms that can lead to remarkably prevalent and devastating neuropsychiatric diseases. Herein we highlight the role of glia, especially the most recently evolved oligodendrocytes and the myelin they produce, in achieving and maintaining optimal brain function. The human brain undergoes exceptionally protracted and pervasive myelination (even throughout its GM) and can thus achieve and maintain the rapid conduction and synchronous timing of neural networks on which optimal function depends. The continuum of increasing myelin vulnerability resulting from the human brain's protracted myelination underlies underappreciated communalities between different disease phenotypes ranging from developmental ones such as schizophrenia (SZ) and bipolar disorder (BD) to degenerative ones such as Alzheimer's disease (AD). These shared vulnerabilities also expose significant yet underexplored opportunities for novel treatment and prevention approaches that have the potential to considerably reduce the tremendous burden of neuropsychiatric disease. GLIA 2014;62:1856–1877
- 1 January 2014
- Vol. 1 (1) , 46-50
Inter-Species Glia Differences: Implications for Successful Translation of Transgenic Rodent Alzheimer's Disease Model Treatment Using Bexarotene.
Despite a multitude of efficacious treatments for the cognitive symptoms and pathology in transgenic mouse models of Alzheimer's disease (AD), success in human trials has been elusive. Rodent-human brain dissimilarities may help explain failures of past human trials and improve outcomes of future ones. This review highlights the essential role of the human brain's exceptional myelination in achieving and maintaining optimal brain functions, as well as underlying its vulnerability to age-related myelin breakdown and the degenerative brain diseases that process can trigger. This alternative myelin-centered perspective is used herein to help explain key disconnects in the existing treatment literature by focusing on recent reports on brain effects of bexarotene, the only marketed retinoid X receptor (RXR) agonist. The myelin perspective exposes significant yet underexplored opportunities for novel treatment and prevention interventions that have the potential to considerably reduce the tremendous burden of degenerative brain diseases.
- 1 January 2014
- Vol. 1 (1) , 46-50
Inter-Species Glia Differences: Implications for Successful Translation of Transgenic Rodent Alzheimer's Disease Model Treatment Using Bexarotene.
Despite a multitude of efficacious treatments for the cognitive symptoms and pathology in transgenic mouse models of Alzheimer's disease (AD), success in human trials has been elusive. Rodent-human brain dissimilarities may help explain failures of past human trials and improve outcomes of future ones. This review highlights the essential role of the human brain's exceptional myelination in achieving and maintaining optimal brain functions, as well as underlying its vulnerability to age-related myelin breakdown and the degenerative brain diseases that process can trigger. This alternative myelin-centered perspective is used herein to help explain key disconnects in the existing treatment literature by focusing on recent reports on brain effects of bexarotene, the only marketed retinoid X receptor (RXR) agonist. The myelin perspective exposes significant yet underexplored opportunities for novel treatment and prevention interventions that have the potential to considerably reduce the tremendous burden of degenerative brain diseases.
- 31 October 2013
- Published by Springer Nature
- p. 281-319
Degenerative Brain Diseases and White Matter Injury
- 31 October 2013
- Published by Springer Nature
- p. 281-319
Degenerative Brain Diseases and White Matter Injury
- 1 December 2012
- Published by Elsevier in Biological Psychiatry
- Vol. 72 (12) , 1026-1034
Multimodal Magnetic Resonance Imaging Assessment of White Matter Aging Trajectories Over the Lifespan of Healthy Individuals
- 1 December 2012
- Published by Elsevier in Biological Psychiatry
- Vol. 72 (12) , 1026-1034
Multimodal Magnetic Resonance Imaging Assessment of White Matter Aging Trajectories Over the Lifespan of Healthy Individuals
- 1 September 2012
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (9) , 1950-1958
Premenopausal hysterectomy is associated with increased brain ferritin iron
- 1 September 2012
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (9) , 1950-1958
Premenopausal hysterectomy is associated with increased brain ferritin iron
- 1 September 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 140 (1-3) , 122-128
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia
- 1 September 2012
- Published by Elsevier in Schizophrenia Research
- Vol. 140 (1-3) , 122-128
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia
- 1 June 2012
- Published by Elsevier in Neuropharmacology
- Vol. 62 (7) , 2137-2153
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
- 1 June 2012
- Published by Elsevier in Neuropharmacology
- Vol. 62 (7) , 2137-2153
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
- 1 October 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 132 (1) , 35-41
Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
- 1 October 2011
- Published by Elsevier in Schizophrenia Research
- Vol. 132 (1) , 35-41
Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
- 1 August 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (8) , 1341-1371
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
- 1 August 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (8) , 1341-1371
Alzheimer's disease as homeostatic responses to age-related myelin breakdown